Security key
00972G207
Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value (AKTX)
CUSIP: 00972G207
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Ordinary Shares, $0.000000005 par value
- Shares outstanding
- 94,284,567,045
- Total 13F shares
- 304,298
- Share change
- -18,485
- Total reported value
- $377,330
- Price per share
- $1.24
- Number of holders
- 10
- Value change
- -$22,653
- Number of sells
- 5
Report period
Q1 2025
Institutions
10
Top holders
10
Reporting periods
Holder history for CUSIP 00972G207
Recent filing periods:
Top shareholders of AKTX - Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Palo Alto Investors LP |
13F
|
Company |
0%
|
146,024
|
$178,149 | — | 31 Dec 2024 | |
| Omnia Family Wealth, LLC |
13F
|
Company |
0%
|
87,628
|
$106,906 | — | 31 Dec 2024 | |
| Cerity Partners LLC |
13F
|
Company |
0%
|
23,643
|
$28,844 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0%
|
23,465
|
$28,627 | — | 31 Dec 2024 | |
| Cresset Asset Management, LLC |
13F
|
Company |
0%
|
18,408
|
$22,458 | — | 31 Dec 2024 | |
| Catalina Capital Group, LLC |
13F
|
Company |
0%
|
13,105
|
$15,988 | — | 31 Dec 2024 | |
| Accent Capital Management, LLC |
13F
|
Company |
0%
|
10,000
|
$12,200 | — | 31 Dec 2024 | |
| Torsten Hombeck |
3/4/5
|
CFO |
—
mixed-class rows
|
200,400
mixed-class rows
|
$468 | — | 20 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
194
|
$237 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
150
|
$183 | — | 31 Dec 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
100
|
$122 | — | 31 Dec 2024 | |
| Truvestments Capital LLC |
13F
|
Company |
0%
|
50
|
$61 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
6
|
$7 | — | 31 Dec 2024 | |
| Cornerstone Planning Group LLC |
13F
|
Company |
0%
|
5
|
$6 | — | 31 Dec 2024 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
5
|
$6 | — | 31 Dec 2024 | |
| Rachelle Suzanne Jacques |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
1,018,027,792
|
— | — | 26 Apr 2024 | |
| Wendy F. Dicicco |
3/4/5
|
Interim CFO |
—
class O/S missing
|
158,473,915
|
— | — | 01 May 2024 | |
| Donald A. Williams |
3/4/5
|
Director |
—
mixed-class rows
|
25,000,000
mixed-class rows
|
— | — | 28 Jun 2024 | |
| Michael Grissinger |
3/4/5
|
Director |
—
mixed-class rows
|
25,000,000
mixed-class rows
|
— | — | 28 Jun 2024 | |
| Mohamed Wa'El Ahmed Hashad |
3/4/5
|
Director |
—
class O/S missing
|
5,000,000
|
— | — | 28 Jun 2024 |
Institutional Holders of Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value (AKTX) as of Q1 2025
As of 31 Mar 2025,
Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value (AKTX) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
304,298 shares.
The largest 10 holders included
Palo Alto Investors LP, Omnia Family Wealth, LLC, Cerity Partners LLC, Cresset Asset Management, LLC, RENAISSANCE TECHNOLOGIES LLC, Accent Capital Management, LLC, BANK OF AMERICA CORP /DE/, Truvestments Capital LLC, MORGAN STANLEY, and Cornerstone Planning Group LLC.
This page lists
10
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
14
Q1 2025 holders
10
Holder diff
-4
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.